Pharmacodynamics and Gene Expression Analysis of Patients with Renal Cell Carcinoma Treated with Combination Nivolumab and TPST-1120 in a Phase I Clinical Trial (NCT03829436)

Publication Date

2024

Presented At:

ASCO Genitourinary Cancers Symposium

Content Type

Poster

Publisher's Site:

View at Publisher Website

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS